Prediction model of total pubertal growth in idiopathic growth hormone deficiency: analysis of data from KIGS.
نویسندگان
چکیده
Accessible online at: www.karger.com/hre When discussing total pubertal growth, it is essential that the times of onset and completion of puberty are defined accurately. For example, Gasser and colleagues [1] studied growth curves from boys and girls and defined the onset of puberty as the nadir of growth velocity (i.e. zero growth acceleration). The end of puberty was defined as the point of minimum growth acceleration. This is in contrast to Marshall and Tanner’s definition of puberty, which is based on clinical signs such as genital and breast development [2]. Marshall and Tanner found that the onset of puberty was at 11.6 years in boys and 11.2 years in girls, with a total pubertal duration of about 3 years [2], whereas Gasser et al., using growth data, showed that the onset of puberty was at 10.9 years in boys and 9.7 years in girls, with a pubertal duration of 4 years [1]. Total pubertal growth was therefore greater when assessed using the methods of Gasser et al. with a difference of 3.7 cm in boys and 9.4 cm in girls [1]. We studied 303 children from KIGS (Pharmacia International Growth Database) who had idiopathic growth hormone (GH) deficiency and a GH level of less than 10 ng/ml in response to provocative testing. Patients had received at least 5 years of GH replacement, with at least 2 years of pre-pubertal and 2 years of post-pubertal therapy. For this study, the age at onset of puberty had to be between 10 and 17 years in boys and between 9 and 16 years in girls. The age at the end of puberty was over 16 years in boys and over 14 years in girls. Height velocity at the time of the analysis needed to be less than 2 cm/year and patients were receiving a constant dose of GH, administered as six or more injections per week. The results are summarized in table 1. Final height was reached at about 18 years in boys and 16 years in girls. Final height in boys was 0.7 standard deviations (SD) with a total pubertal growth of 25.3 cm. In girls, the final height was –1.7 SD, with a total pubertal growth of only 16 cm. Similar results were seen in an analysis of 36 patients (24 boys, 12 girls) from the University Children’s Hospital, Tübingen, Germany. When simple linear correlations were performed on the KIGS data, total pubertal growth correlated positively with both the age at onset of puberty and with the distance from target height, expressed as SD. Total pubertal growth also correlated positively with GH dose. Thus, a prediction model was developed with four variables: distance to target height (the greater the distance to target height, the greater the growth when receiving GH); mean GH dose; age at onset of puberty (the younger the age at
منابع مشابه
The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose.
The role of GH treatment during total pubertal growth (TPG) is still unclear. We developed a prediction model for TPG (centimeters) through a multiple regression analysis of various prepubertal parameters in 303 adolescents with idiopathic GH deficiency from the KIGS database. Prepubertal catch-up growth and near-adult height were achieved, and GH dose was kept constant at approximately 30 micr...
متن کاملValidation and calibration of the Kabi Pharmacia International Growth Study prediction model for children with idiopathic growth hormone deficiency.
In 1999 a model was published for prediction of growth in children with idiopathic GH deficiency (IGHD) during GH therapy, derived using data from the Kabi Pharmacia International Growth Study (KIGS) database (Pharmacia \|[amp ]\| Upjohn, Inc., International Growth Database). We validated and calibrated this KIGS model for growth in the first year of GH therapy using data from 136 Dutch childre...
متن کاملEarly-onset idiopathic growth hormone deficiency within KIGS.
Growth hormone (GH) deficiency is normally diagnosed when the affected child is between 6 and 8 years of age and a lack of normal growth first becomes noticeable. Some patients, however, are diagnosed as being GH deficient at a relatively young age (<2 years). These patients differ from the later-diagnosed patients in terms of their background, their characteristics of GH deficiency (GHD) and t...
متن کاملFinal height in children with medulloblastoma treated with growth hormone.
BACKGROUND Medulloblastoma is the most frequent primary solid central nervous system tumour in children. The 5-year survival rate is at present at about 60%. Height in general is severely compromised in survivors. The present study is an extension of the investigation by the author's group of the effect of exogenous growth hormone (GH) among medulloblastoma patients. METHODS A total of 113 pa...
متن کاملPresenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasia
BACKGROUND Optic nerve hypoplasia (ONH) with/or without septo-optic dysplasia (SOD) is a known concomitant of congenital growth hormone deficiency (CGHD). METHODS Demographic and longitudinal data from KIGS, the Pfizer International Growth Database, were compared between 395 subjects with ONH/SOD and CGHD and 158 controls with CGHD without midline pathology. RESULTS ONH/SOD subjects had hig...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Hormone research
دوره 60 Suppl 1 شماره
صفحات -
تاریخ انتشار 2003